185 related articles for article (PubMed ID: 38003785)
1. Participation of Single-Nucleotide Variants in
López-Bielma MF; Falfán-Valencia R; Abarca-Rojano E; Pérez-Rubio G
Pathogens; 2023 Nov; 12(11):. PubMed ID: 38003785
[TBL] [Abstract][Full Text] [Related]
2. IFNAR2 Is Required for Anti-influenza Immunity and Alters Susceptibility to Post-influenza Bacterial Superinfections.
Shepardson KM; Larson K; Johns LL; Stanek K; Cho H; Wellham J; Henderson H; Rynda-Apple A
Front Immunol; 2018; 9():2589. PubMed ID: 30473701
[TBL] [Abstract][Full Text] [Related]
3. Loss-of-function mutations in IFNAR2 in COVID-19 severe infection susceptibility.
Smieszek SP; Polymeropoulos VM; Xiao C; Polymeropoulos CM; Polymeropoulos MH
J Glob Antimicrob Resist; 2021 Sep; 26():239-240. PubMed ID: 34273592
[TBL] [Abstract][Full Text] [Related]
4. Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review.
Alhumaid S; Al Mutared KM; Al Alawi Z; Sabr Z; Alkhars O; Alabdulqader M; Al Dossary N; ALShakhs FM; Majzoub RA; Alalawi YH; Al Noaim K; Alnaim AA; Al Ghamdi MA; Alahmari AA; Albattat SS; Almubarak YS; Al Abdulmohsen EM; Al Shaikh H; Alobaidan ME; Almusallam HH; Alhassan FM; Alamer MA; Al-Hajji JA; Al-Hajji DA; Alkadi AA; Al Mutair A; Rabaan AA
Allergy Asthma Clin Immunol; 2023 Aug; 19(1):69. PubMed ID: 37559153
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. IFNAR2 relevance in the clinical outcome of individuals with severe COVID-19.
Fricke-Galindo I; Martínez-Morales A; Chávez-Galán L; Ocaña-Guzmán R; Buendía-Roldán I; Pérez-Rubio G; Hernández-Zenteno RJ; Verónica-Aguilar A; Alarcón-Dionet A; Aguilar-Duran H; Gutiérrez-Pérez IA; Zaragoza-García O; Alanis-Ponce J; Camarena A; Bautista-Becerril B; Nava-Quiroz KJ; Mejía M; Guzmán-Guzmán IP; Falfán-Valencia R
Front Immunol; 2022; 13():949413. PubMed ID: 35967349
[TBL] [Abstract][Full Text] [Related]
7. Specific activation of embryonic IFNAR1 and endometrial IFNAR2 induced by embryonic IFNτ directs normal uterine fate for bovine early implantation.
Wang X; Chen C; Wang L; Su Y; Li B; Xiao L; Lin Z; Sheng X; Qi X; Ni H; Guo Y
J Reprod Immunol; 2022 Sep; 153():103677. PubMed ID: 35907379
[TBL] [Abstract][Full Text] [Related]
8. Expression of IFNAR1 and IFNAR2 in cattle placenta during early pregnancy.
Wang W; Liu R; Liang X; Zhao Q; Qu P; Yao K; Jiang M; Luo Y; Zhang W; Qing S
Reprod Domest Anim; 2018 Apr; 53(2):385-392. PubMed ID: 29194800
[TBL] [Abstract][Full Text] [Related]
9. Deleterious single nucleotide polymorphisms (SNPs) of human IFNAR2 gene facilitate COVID-19 severity in patients: a comprehensive
Akter S; Roy AS; Tonmoy MIQ; Islam MS
J Biomol Struct Dyn; 2022; 40(21):11173-11189. PubMed ID: 34355676
[TBL] [Abstract][Full Text] [Related]
10. Synthetic mimetics assigned a major role to IFNAR2 in type I interferon signaling.
Zoellner N; Coesfeld N; De Vos FH; Denter J; Xu HC; Zimmer E; Knebel B; Al-Hasani H; Mossner S; Lang PA; Floss DM; Scheller J
Front Microbiol; 2022; 13():947169. PubMed ID: 36118237
[TBL] [Abstract][Full Text] [Related]
11. Differential receptor subunit affinities of type I interferons govern differential signal activation.
Jaks E; Gavutis M; Uzé G; Martal J; Piehler J
J Mol Biol; 2007 Feb; 366(2):525-39. PubMed ID: 17174979
[TBL] [Abstract][Full Text] [Related]
12. Characterization of interferon α and β receptor IFNAR1 and IFNAR2 expression and regulation in the uterine endometrium during the estrous cycle and pregnancy in pigs.
Jang H; Choi Y; Yoo I; Han J; Kim M; Ka H
Theriogenology; 2017 Jan; 88():166-173. PubMed ID: 27769575
[TBL] [Abstract][Full Text] [Related]
13. Ligand-induced assembling of the type I interferon receptor on supported lipid bilayers.
Lamken P; Lata S; Gavutis M; Piehler J
J Mol Biol; 2004 Jul; 341(1):303-18. PubMed ID: 15312780
[TBL] [Abstract][Full Text] [Related]
14. Immune response genes receptors expression and polymorphisms in relation to multiple sclerosis susceptibility and response to INF-β therapy.
Karam RA; Rezk NA; Amer MM; Fathy HA
IUBMB Life; 2016 Sep; 68(9):727-34. PubMed ID: 27346865
[TBL] [Abstract][Full Text] [Related]
15. Expression of interferon receptor genes (IFNAR1 and IFNAR2 mRNA) in the liver may predict outcome after interferon therapy in patients with chronic genotype 2a or 2b hepatitis C virus infection.
Morita K; Tanaka K; Saito S; Kitamura T; Kondo M; Sakaguchi T; Morimoto M; Sekihara H
J Clin Gastroenterol; 1998 Mar; 26(2):135-40. PubMed ID: 9563926
[TBL] [Abstract][Full Text] [Related]
16. NMR mapping of the IFNAR1-EC binding site on IFNalpha2 reveals allosteric changes in the IFNAR2-EC binding site.
Akabayov SR; Biron Z; Lamken P; Piehler J; Anglister J
Biochemistry; 2010 Feb; 49(4):687-95. PubMed ID: 20047337
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.
Arduini RM; Strauch KL; Runkel LA; Carlson MM; Hronowski X; Foley SF; Young CN; Cheng W; Hochman PS; Baker DP
Protein Sci; 1999 Sep; 8(9):1867-77. PubMed ID: 10493588
[TBL] [Abstract][Full Text] [Related]
18. Association study of IFNAR2 and IL10RB genes with the susceptibility and interferon response in HBV infection.
Gong QM; Kong XF; Yang ZT; Xu J; Wang L; Li XH; Jin GD; Gao J; Zhang DH; Jiang JH; Lu ZM; Zhang XX
J Viral Hepat; 2009 Sep; 16(9):674-80. PubMed ID: 19714778
[TBL] [Abstract][Full Text] [Related]
19. The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein.
Croze E; Russell-Harde D; Wagner TC; Pu H; Pfeffer LM; Perez HD
J Biol Chem; 1996 Dec; 271(52):33165-8. PubMed ID: 8969169
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of cytokine-mediated receptor assembly using engineered FC heterodimers.
Deshpande A; Putcha BD; Kuruganti S; Walter MR
Protein Sci; 2013 Aug; 22(8):1100-8. PubMed ID: 23703950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
